NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

11218	Companies
248758	Keywords
176532	Articles
134595	Press releases

Home
Companies
NANOBIOTIX

BRIEF

published on 05/14/2024 at 22:20, 2 years 5 months ago

NANOBIOTIX Lance une Étude de Phase 2 sur le Traitement du Cancer du Poumon avec FDA Approval

FDA Étude De Phase 2 NANOBIOTIX Cancer Du Poumon NBTXR3
BRIEF

published on 05/14/2024 at 22:20, 2 years 5 months ago

NANOBIOTIX Launches Phase 2 Lung Cancer Treatment Study with FDA Approval

FDA Phase 2 Study NANOBIOTIX NBTXR3 Lung Cancer
PRESS RELEASE

published on 05/14/2024 at 22:15, 2 years 5 months ago

NANOBIOTIX annonce l'acceptation par l'Agence américaine du médicament, la FDA, d'un protocole pour une nouvelle étude randomisée de Phase 2 évaluant NBTXR3 pour les patients atteints d'un cancer du poumon de stade trois
Nanobiotix annonce l'acceptation par la FDA d'un protocole pour une nouvelle étude de phase 2 sur NBTXR3 pour le cancer du poumon de stade III

FDA Étude De Phase 2 NANOBIOTIX Cancer Du Poumon NBTXR3
PRESS RELEASE

published on 05/14/2024 at 22:15, 2 years 5 months ago

NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer
Nanobiotix announces US FDA protocol acceptance for new randomized Phase 2 study on NBTXR3 for stage three lung cancer patients

Phase 2 Study NANOBIOTIX NBTXR3 Lung Cancer FDA Protocol

Accesswire

Published on 10/23/2026 at 02:20, 1 hour 23 minutes ago

Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 4 hours 13 minutes ago

Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 5 hours 13 minutes ago

Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 11 hours 43 minutes ago

Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 13 hours 13 minutes ago

Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components

View all ACCESSWIRE

EQS Group

Published on 10/23/2026 at 01:55, 1 hour 48 minutes ago

Guardian. For Family｜TIGGO7 Crash Test Results Demonstrate CHERY's Commitment to Family Safety
Published on 10/22/2026 at 22:10, 5 hours 33 minutes ago

Quantinuum to Report Third Quarter Financial Results on November 5, 2026
Published on 10/22/2026 at 20:00, 7 hours 43 minutes ago

Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Published on 10/22/2026 at 19:45, 7 hours 58 minutes ago

EUROPLASMA: Les Forges de Tarbes sollicitent l’ouverture d’une procédure de redressement judiciaire
Published on 10/22/2026 at 18:45, 8 hours 58 minutes ago

Swedish Export Credit Corporation (SEK): Europe's defence build-up opens opportunities for Swedish companies in Germany

Les Echos

Published on 10/22/2026 at 18:00, 9 hours 43 minutes ago

THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 9 hours 43 minutes ago

THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 9 hours 43 minutes ago

bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 9 hours 43 minutes ago

bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel : une avancée pour améliorer la santé des femmes grâce au diagnostic moléculaire rapide
Published on 10/22/2026 at 18:00, 9 hours 43 minutes ago

1er semestre 2026 : résultats opérationnels en nette amélioration

View all LES ECHOS COMFI WIRE